We’ve all had a moment where we arrived at the grocery store and can’t remember passing any of the stoplights along the way. We’re halfway down an aisle and scrambling to remember what we even needed. Our mind is in overdrive trying to sort through our ever-growing to-do list. We’ve been there when just making it through the next task is hard. But the normal stresses of life aren’t the only thing YOU have to deal with. Nora McInerny hosts The Head Start: Embracing the Journey, a new podcast ...
…
continue reading
Content provided by Spine Talk and Texas Back Institute. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Spine Talk and Texas Back Institute or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
Dr. Tom Kosztowski talks about How a New Treatment for ADHD Might Offer Relief for Epilepsy
MP3•Episode home
Manage episode 240739565 series 1191016
Content provided by Spine Talk and Texas Back Institute. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Spine Talk and Texas Back Institute or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Read the Full story here: https://texasback.com/how-a-new-treatment-for-adhd-might-offer-relief-for-epilepsy/ There’s new hope for those who suffer from the debilitating condition of epilepsy. A minimally invasive procedure recently approved by the U.S. Food and Drug Administration (FDA) for treating Attention Deficit Hyperactivity Disorder (ADHD) in children holds promise for helping the 65 million people suffering from epilepsy. One of the neurosurgeons who helped evaluate this new treatment for the FDA is a member of the team of specialists at Texas Back Institute – Dr. Thomas Kosztowski. Do you or a loved one suffer from epilepsy? Have you seen symptoms of this condition and are concerned about treatment? Schedule an appointment with Dr. Kosztowski or other neurosurgeons at Texas Back Institute. Read the Full story here: https://texasback.com/how-a-new-treatment-for-adhd-might-offer-relief-for-epilepsy/
…
continue reading
54 episodes
MP3•Episode home
Manage episode 240739565 series 1191016
Content provided by Spine Talk and Texas Back Institute. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Spine Talk and Texas Back Institute or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Read the Full story here: https://texasback.com/how-a-new-treatment-for-adhd-might-offer-relief-for-epilepsy/ There’s new hope for those who suffer from the debilitating condition of epilepsy. A minimally invasive procedure recently approved by the U.S. Food and Drug Administration (FDA) for treating Attention Deficit Hyperactivity Disorder (ADHD) in children holds promise for helping the 65 million people suffering from epilepsy. One of the neurosurgeons who helped evaluate this new treatment for the FDA is a member of the team of specialists at Texas Back Institute – Dr. Thomas Kosztowski. Do you or a loved one suffer from epilepsy? Have you seen symptoms of this condition and are concerned about treatment? Schedule an appointment with Dr. Kosztowski or other neurosurgeons at Texas Back Institute. Read the Full story here: https://texasback.com/how-a-new-treatment-for-adhd-might-offer-relief-for-epilepsy/
…
continue reading
54 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.